Development will be built alongside GSK’s existing Global R&D centre and Stevenage Bioscience Catalyst, the leading location for advanced therapeutics in the UK
The new campus, which will be one of the largest of its kind in the UK and Europe, will be built alongside GSK’s existing Global R&D centre in the town. The developement with deliver up to GBP900m of new investment alongside an estimated 1.4 million square feet of laboratory and office facilities, providing space for up to 5,000 new jobs.
Plans for the campus were initially announced in 2021 and build upon the existing presence of both GSK and Stevenage Bioscience Catalyst (SBC), an organisation which provides a supportive environment for companies to develop and commercialise cutting edge advanced therapeutics. The campus is intended to help meet the growing demand for state-of-the-art commercial and laboratory space from both emerging and established life science firms.